港股異動丨歐舒丹高開超7%,黑石考慮收購歐舒丹的可能性
歐舒丹(0973.HK)跳空高開7.69%報28港元,股價創2023年8月14日以來新高,最新市值414億港元。有知情人士透露,黑石集團正考慮收購護膚品公司歐舒丹。據悉,黑石集團一直在進行初步盡職調查,評估對歐舒丹發出收購要約的可能性。這家總部位於盧森堡的公司於2010年在香港交易所上市。該股股價2022年見頂,達到IPO價的兩倍以上,但之後出現回落。彭博數據顯示,截至週一收盤,歐舒丹的企業價值約為其息税折舊及攤銷前利潤的10倍,而同類公司的平均值超過13倍。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.